Paganetti et al., 1996 - Google Patents

Amyloid precursor protein truncated at any of the γ‐secretase sites is not cleaved to β‐amyloid

Paganetti et al., 1996

Document ID
16256171347877791070
Author
Paganetti P
Lis M
Klafki H
Staufenbiel M
Publication year
Publication venue
Journal of neuroscience research

External Links

Snippet

Abstract βA4 secretion occurs upon processing of amyloid protein precursor (APP) by β‐ secretase (N‐terminus of βA4) and γ‐secretase (C‐terminus). To determine the sequence of these activities and the processing intermediate of βA4, we expressed several truncated …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Similar Documents

Publication Publication Date Title
Paganetti et al. Amyloid precursor protein truncated at any of the γ‐secretase sites is not cleaved to β‐amyloid
US5652092A (en) Amyloid precursor proteins and method of using same to assess agents which down-regulate formation of β-amyloid peptide
Thinakaran et al. Stable association of presenilin derivatives and absence of presenilin interactions with APP
Weidemann et al. Formation of stable complexes between two Alzheimer's disease gene products: presenilin-2 and β-amyloid precursor protein
Hashimoto et al. CLAC: a novel Alzheimer amyloid plaque component derived from a transmembrane precursor, CLAC‐P/collagen type XXV
CA2437453C (en) Conformationally abnormal forms of tau proteins and specific antibodies thereto
EP0906577B1 (en) Screening compounds for the ability to alter the production of amyloid-beta peptide
Slunt et al. Expression of a ubiquitous, cross-reactive homologue of the mouse beta-amyloid precursor protein (APP).
US20090023158A1 (en) Compositions and Methods for Identifying Substrate Specificity of Inhibitors of Gamma Secretase
JP2006149394A (en) beta-SECRETASE, ANTIBODY AGAINST beta-SECRETASE, AND ASSAY FOR DETECTING beta-SECRETASE INHIBITION
JPH10509797A (en) Method for assisting diagnosis of Alzheimer's disease by measuring amyloid β peptide (X- ≧ 41) and tau
US20090163594A1 (en) Triple Assay System for Identifying Substrate Selectivity of Gamma Secretase Inhibitors
JP4454230B2 (en) β-secretase substrate and use thereof
WO2007022015A1 (en) Methods to evaluate amyloid beta-lowering agents using wild-type mice
Matsumoto et al. Abnormal and deficient processing of β-amyloid precursor protein in familial Alzheimer's disease lymphoblastoid cells
US7049138B2 (en) Epitope-tagged beta-amyloid precursor protein and DNA encoding the same
Baumann et al. Distinct processing of endogenous and overexpressed recombinant presenilin 1
DK1305406T4 (en) The modulation of gamma-secretase activity
Conn et al. Monoclonal antibodies against the human metalloprotease EC 3.4. 24.15 label neurofibrillary tangles in Alzheimer's disease brain
Ikeuchi et al. Cell-free generation of the Notch1 intracellular domain (NICD) and APP-CTFγ: Evidence for distinct intramembranous “γ-secretase” activities
Anderson et al. Cellular forms of the rat and human ß-amyloid precursor protein (BAPP)
Okochi et al. Presenilin 1 cleavage is a universal event in human organs
US20040038338A1 (en) Influence of LRP cytoplasmic domain on Abeta production
DUONG et al. Neuronal Expression and Intracellular Localization of Presenilins in